Document Detail


Influence of nicorandil, an antianginal agent, on the therapeutic and toxic cardiovascular actions of ouabain in the anaesthetized dog.
MedLine Citation:
PMID:  6235076     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of nicorandil were investigated on ouabain-induced cardiovascular actions in pentobarbitone-anaesthetized dogs. Nicorandil (500 micrograms/kg per h) and ouabain (100 micrograms/kg per h), alone and in combination, were infused intravenously to three groups of dogs. Nicorandil gradually decreased systemic blood pressure, pressure-rate product, left ventricular systolic pressure, and coronary vascular resistance, but did not significantly affect heart rate, left ventricular dP/dt max, coronary blood flow, plasma electrolyte concentrations and ECG patterns. The lethal dose of ouabain was 122 micrograms/kg (s.e.m. = 3, n = 6) and the dose required to elicit ventricular premature beats was 63 micrograms/kg (s.e.m. = 3, n = 6). When nicorandil and ouabain were simultaneously infused intravenously, nicorandil did not affect either the lethal dose of ouabain or the dose required to produce ventricular premature beats, but it significantly inhibited the marked increases in coronary vascular resistance and systemic blood pressure induced by ouabain alone. Even in combination with nicorandil, ouabain maintained its own positive inotropic effect. The results indicate that the combination of ouabain with nicorandil may be beneficial in some conditions of angina pectoris.
Authors:
Y Nakamura; M Akima; K Sakai
Related Documents :
10517206 - Velocity distribution in the ascending aorta in pigs during chronotropic and inotropic ...
22323666 - The organizational stress measure: an integrated methodology for assessing job-stress a...
22333756 - A01 effect of dexmedetomidine on hemodynamic responses during induction period, skull...
22304836 - The effects of daily consumption of grapefruit on body weight, lipids, and blood pressu...
2045156 - Androgen receptor and the testes influence hypertension in a hybrid rat model.
10517206 - Velocity distribution in the ascending aorta in pigs during chronotropic and inotropic ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  11     ISSN:  0305-1870     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:    1984 May-Jun
Date Detail:
Created Date:  1984-09-18     Completed Date:  1984-09-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  275-83     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina Pectoris / drug therapy
Animals
Blood Pressure / drug effects
Dogs
Drug Synergism
Drug Therapy, Combination
Female
Heart Rate / drug effects
Hemodynamics / drug effects*
Male
Niacinamide / analogs & derivatives*,  metabolism,  pharmacology
Nicorandil
Ouabain / pharmacology*,  toxicity
Vascular Resistance / drug effects
Vasodilator Agents / pharmacology*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 630-60-4/Ouabain; 65141-46-0/Nicorandil; 98-92-0/Niacinamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
Next Document:  A method of repair for Achilles tendon ruptures without cast immobilization. Preliminary report.